Terms: = Breast cancer AND NFATC2, ENSG00000101096, 4773, Q13469, NFATP, NFAT1, KIAA0611 AND Treatment
11 results:
1. STIM2 promotes the invasion and metastasis of breast cancer cells through the nfat1/TGF-β1 pathway.
Cheng H; Chen L; Fang Z; Wan Q; Du Z; Ma N; Guo G; Lu W
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(6):55-61. PubMed ID: 35818214
[TBL] [Abstract] [Full Text] [Related]
2. A Novel Prognostic Four-Gene Signature of breast cancer Identified by Integrated Bioinformatics Analysis.
Zhao X; Yan H; Yan X; Chen Z; Zhuo R
Dis Markers; 2022; 2022():5925982. PubMed ID: 35265226
[TBL] [Abstract] [Full Text] [Related]
3. Invasion and migration of MDA-MB-231 cells are inhibited by block of AhR and NFAT: role of AhR/nfat1/β4 integrin signaling.
Shadboorestan A; Tarfiei GA; Montazeri H; Sepand MR; Zangooei M; Khedri A; Ostad SN; Ghahremani MH
J Appl Toxicol; 2019 Feb; 39(2):375-384. PubMed ID: 30294794
[TBL] [Abstract] [Full Text] [Related]
4. TIS21
Sundaramoorthy S; Devanand P; Ryu MS; Song KY; Noh DY; Lim IK
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1445-1462. PubMed ID: 29808317
[TBL] [Abstract] [Full Text] [Related]
5. Experimental Therapy of Advanced breast cancer: Targeting nfat1-MDM2-p53 Pathway.
Qin JJ; Wang W; Zhang R
Prog Mol Biol Transl Sci; 2017; 151():195-216. PubMed ID: 29096894
[TBL] [Abstract] [Full Text] [Related]
6. Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer.
Rampurwala M; Wisinski KB; Burkard ME; Ehsani S; O'Regan RM; Carmichael L; Kim K; Kolesar J; Tevaarwerk AJ
Invest New Drugs; 2017 Feb; 35(1):87-94. PubMed ID: 27826831
[TBL] [Abstract] [Full Text] [Related]
7. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
[TBL] [Abstract] [Full Text] [Related]
8. [Correlation of Her-2 overexpression with endocrine status and response to tamoxifen treatment in patients with breast cancer].
Zhang J; Zhang JH; Liu Y; Hao XM; Fang ZX; Li SL
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3268-71. PubMed ID: 18396622
[TBL] [Abstract] [Full Text] [Related]
9. Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells.
Dejmek J; Säfholm A; Kamp Nielsen C; Andersson T; Leandersson K
Mol Cell Biol; 2006 Aug; 26(16):6024-36. PubMed ID: 16880514
[TBL] [Abstract] [Full Text] [Related]
10. Validation of the inverse water volumetry method: A new gold standard for arm volume measurements.
Damstra RJ; Glazenburg EJ; Hop WC
Breast Cancer Res Treat; 2006 Oct; 99(3):267-73. PubMed ID: 16752072
[TBL] [Abstract] [Full Text] [Related]
11. Ultrasonography of the endometrium and endometrial pathology under tamoxifen treatment.
Friedrich M; Villena-Heinsen C; Mink D; Endres V; Reitnauer K; Schmidt W
Eur J Gynaecol Oncol; 1998; 19(6):536-40. PubMed ID: 10215436
[TBL] [Abstract] [Full Text] [Related]
